NCT05904002 is a NA clinical trial of pulmicort inhaler in Asthmatic, sponsored by Cairo University.

Who is sponsoring NCT05904002?

NCT05904002 is sponsored by Cairo University.

What drugs are being tested in NCT05904002?

Interventions in NCT05904002: pulmicort inhaler, Incentive spirometer treatment.

What condition does NCT05904002 study?

NCT05904002 studies Asthmatic, Pregnant With Complication.

Is NCT05904002 still recruiting?

NCT05904002 is currently completed. Last updated 15 June 2023.

Last reviewed 2023-06-15 · How we verify

NCT05904002

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Incentive Spirometery on Asthmatic Pregnant Women

Completed NA Last updated 15 June 2023

What this trial tests

NA trial testing pulmicort inhaler in Asthmatic in 60 participants. Completed in 15 February 2022.

Timeline

20 September 2020

Primary endpoint
15 September 2021

15 February 2022

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	60
Start date	20 September 2020
Primary completion	15 September 2021
Estimated completion	15 February 2022
Sites	1 location across Egypt

Drugs / interventions tested

pulmicort inhaler — full drug profile →
Incentive spirometer treatment

Conditions studied

Asthmatic — all drugs for Asthmatic →
Pregnant With Complication — all drugs for Pregnant With Complication →

Sponsor

Cairo University

Who can join

Adults 30 to 40, any sex, with Asthmatic or Pregnant With Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the effect of the incentive spirometer on asthma during pregnancy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05904002 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 15 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05904002.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing